Drug Shortage Report for ADYNOVATE
Report ID | 128401 |
Drug Identification Number | 02498626 |
Brand name | ADYNOVATE |
Common or Proper name | Antihemophilic Factor (Recombinant), Pegylated |
Company Name | TAKEDA CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | ANTIHEMOPHILIC FACTOR |
Strength(s) | 3000UNIT |
Dosage form(s) | KIT POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 5mL, 3000 IU/UI |
ATC code | B02BD |
ATC description | VITAMIN K AND OTHER HEMOSTATICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2020-12-01 |
Actual start date | 2020-12-01 |
Estimated end date | 2020-12-31 |
Actual end date | 2021-01-05 |
Shortage status | Resolved |
Updated date | 2021-01-06 |
Company comments | Resolved as of 05Jan2021 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 22 ADELAIDE STREET WEST TORONTO, ONTARIO CANADA M5H 4E3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2021-01-06 | English | Compare |
v8 | 2021-01-05 | French | Compare |
v7 | 2021-01-05 | English | Compare |
v6 | 2021-01-05 | French | Compare |
v5 | 2021-01-05 | French | Compare |
v4 | 2021-01-05 | English | Compare |
v3 | 2020-12-02 | English | Compare |
v2 | 2020-11-13 | French | Compare |
v1 | 2020-11-13 | English | Compare |
Showing 1 to 9 of 9